Drug
Valproate Sodium
Valproate Sodium is a pharmaceutical drug with 5 clinical trials. Historical success rate of 75.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
75.0%
Based on 3 completed trials
Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
67%(2 trials)
Terminated
1(20%)
Phase Distribution
Ph phase_4
2
40%
Ph phase_3
2
40%
Phase Distribution
0
Early Stage
0
Mid Stage
4
Late Stage
Phase Distribution4 total trials
Phase 3Large-scale testing
2(50.0%)
Phase 4Post-market surveillance
2(50.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
75.0%
3 of 4 finished
Non-Completion Rate
25.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(3)
Terminated(1)
Other(1)
Detailed Status
Completed3
unknown1
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
75.0%
Most Advanced
Phase 4
Trials by Phase
Phase 32 (50.0%)
Phase 42 (50.0%)
Trials by Status
unknown120%
completed360%
terminated120%
Recent Activity
0 active trials
Showing 5 of 5
terminatedphase_4
Antiseizure Medication in Seizure Networks at Early Acute Brain Injury
NCT06081283
completedphase_3
Comparative Study Between Valproate and Memantine in the Prophylactic Management of Episodic Migraine.
NCT04698525
unknown
Exploration of Genotype Based Personalized Prescription of Valproate Sodium in Anti-epileptic Treatment
NCT01172626
completedphase_4
VALID : VAlproate Versus LIthium in Bipolar Disorders
NCT00264173
completedphase_3
Phase III Double Blind Trial of Valproate Sodium for Prophylaxis of Post Traumatic Seizures
NCT00004817
Clinical Trials (5)
Showing 5 of 5 trials
NCT06081283Phase 4
Antiseizure Medication in Seizure Networks at Early Acute Brain Injury
NCT04698525Phase 3
Comparative Study Between Valproate and Memantine in the Prophylactic Management of Episodic Migraine.
NCT01172626
Exploration of Genotype Based Personalized Prescription of Valproate Sodium in Anti-epileptic Treatment
NCT00264173Phase 4
VALID : VAlproate Versus LIthium in Bipolar Disorders
NCT00004817Phase 3
Phase III Double Blind Trial of Valproate Sodium for Prophylaxis of Post Traumatic Seizures
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5